Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Centro de Investigaciones en Bioquímica Clínica e Inmunología-Consejo Nacional de Investigaciones Científicas y Técnicas (CIBICI-CONICET), Córdoba, Argentina.
Thyroid. 2022 Jan;32(1):19-27. doi: 10.1089/thy.2021.0344. Epub 2021 Dec 24.
The sodium/iodide symporter (NIS) mediates active iodide accumulation in the thyroid follicular cell. Autosomal recessive iodide transport defect (ITD)-causing loss-of-function NIS variants lead to dyshormonogenic congenital hypothyroidism due to deficient iodide accumulation for thyroid hormonogenesis. Here, we aimed to identify, and if so to functionally characterize, novel ITD-causing NIS pathogenic variants in a patient diagnosed with severe dyshormonogenic congenital hypothyroidism due to a defect in iodide accumulation in the thyroid follicular cell, as suggested by nondetectable radioiodide accumulation in a normally located thyroid gland, as well as in salivary glands. The proposita NIS-coding gene was sequenced using Sanger sequencing. analysis and functional characterization of the novel NIS variants were performed. Sanger sequencing revealed novel compound heterozygous gene variants (c.970-3C>A and c.1106A>T, p.D369V). analysis suggested that c.970-3C>A disrupts the canonical splice acceptor site located in intron 7. Splicing minigene reporter assay revealed that c.970-3C>A causes exon 8 skipping during NIS pre-mRNA splicing leading to the NIS pathogenic variant p.Y324H*148. Moreover, analysis indicated p.D369V as pathogenic. Functional studies demonstrated that p.D369V NIS does not mediate iodide accumulation, as p.D369V causes NIS to be retained in the endoplasmic reticulum. Mechanistically, we propose an intramolecular ionic interaction involving the β carboxyl group of D369 and the guanidinium group of R130, located in transmembrane segment 4. Of note, an Asp residue at position 369-which is highly conserved in SLC5A family members-is required for functional NIS expression at the plasma membrane. We uncovered a critical intramolecular interaction between R130 and D369 required for NIS maturation and plasma membrane expression. Moreover, we identified the first intronic variant causing aberrant NIS pre-mRNA splicing, thus expanding the mutational landscape in the gene leading to dyshormonogenic congenital hypothyroidism.
钠/碘同向转运体(NIS)介导甲状腺滤泡细胞中碘的主动蓄积。常染色体隐性碘转运缺陷(ITD)导致的 NIS 功能丧失变异体导致甲状腺激素生成的碘蓄积缺陷导致先天性甲状腺功能减退症。在这里,我们旨在鉴定并如果可能的话,对一名因甲状腺滤泡细胞碘蓄积缺陷导致严重先天性甲状腺功能减退症的患者中的新的 ITD 致病 NIS 变异体进行功能特征分析,正如放射性碘蓄积在正常位置的甲状腺以及唾液腺中无法检测到所表明的那样。使用 Sanger 测序对先证者的 NIS 编码基因进行测序。对新的 NIS 变异体进行分析和功能特征分析。Sanger 测序揭示了新的复合杂合基因突变(c.970-3C>A 和 c.1106A>T,p.D369V)。分析表明,c.970-3C>A 破坏了位于内含子 7 中的经典剪接受体位点。剪接 minigene 报告基因分析表明,c.970-3C>A 导致 NIS 前体 mRNA 剪接过程中外显子 8 跳过,导致 NIS 致病变异 p.Y324H*148。此外,分析表明 p.D369V 为致病性的。功能研究表明,p.D369V NIS 不能介导碘蓄积,因为 p.D369V 导致 NIS 在内质网中保留。从机制上讲,我们提出了一种涉及 D369 的β羧基和位于跨膜片段 4 中的 R130 的胍基的分子内离子相互作用。值得注意的是,位置 369 的天冬氨酸残基-在 SLC5A 家族成员中高度保守-是功能性 NIS 在质膜上表达所必需的。我们发现了一种 R130 和 D369 之间的关键分子内相互作用,该相互作用对于 NIS 的成熟和质膜表达是必需的。此外,我们鉴定了第一个引起异常 NIS 前体 mRNA 剪接的内含子变异体,从而扩展了导致先天性甲状腺功能减退症的 基因中的突变景观。